Cefprozil for Oral Suspension 250 mg/5 mL, Non-fasting
NCT00835354
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
26
Enrollment
INDUSTRY
Sponsor class
Conditions
Healthy
Interventions
DRUG:
Cefprozil for oral suspension 250 mg/5 mL
DRUG:
CEFZIL® for Oral Suspension 250 mg/5mL
Sponsor
Teva Pharmaceuticals USA